Aldeyra Therapeutics, Inc.
ALDX
$1.86
$0.031.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.85M | -43.19M | -50.62M | -57.70M | -55.85M |
| Total Depreciation and Amortization | 252.00K | 251.30K | 250.60K | 249.90K | 249.60K |
| Total Amortization of Deferred Charges | 267.30K | 267.30K | 267.30K | 267.30K | -- |
| Total Other Non-Cash Items | 5.16M | 4.91M | 5.30M | 6.93M | 6.48M |
| Change in Net Operating Assets | -5.18M | -2.31M | 3.77M | 4.55M | 5.91M |
| Cash from Operations | -33.35M | -40.08M | -41.04M | -45.71M | -43.21M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.74M | 30.17M | 10.44M | -7.25M | -44.92M |
| Cash from Investing | 47.74M | 30.17M | 10.44M | -7.25M | -44.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -292.50K | -292.50K | -292.50K | -292.50K |
| Issuance of Common Stock | 1.12M | 1.47M | 1.37M | 1.37M | 388.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -50.00K | -267.30K | -267.30K | -267.30K |
| Cash from Financing | 1.12M | 1.13M | 813.20K | 813.20K | -171.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.51M | -8.78M | -29.79M | -52.14M | -88.30M |